Noto D, Cefalu AB, Barbagallo CM, et al. Cystatin C levels are decreased in acute myocardial infarction: effect of cystatin C G73A gene polymorphism on plasma level[J]. Int J Cardiol, 2005, 101(2): 213-217.
Sukhova GK, Wang B, Libby P, et al. Cystatin C deficiency increase elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice[J]. Circ Res, 2005, 96(3): 368-375.
[4]
Eriksson P, DeguchiH, Samnegard A, et al. Human evidence that the cystatin C gene is imp licated in focal progression of coronary artery disease[J]. Arterioscler Thromb Vasc Biol, 2004, 24(3): 551-557.
[5]
Ichimoto E, Jo K, Kobayashi Y, et al. Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction[J]. Circ J, 2009, 73(9): 1669-1673.
[6]
Frendéus KH, Wallin H, Janciauskiene S, et al. Macrophage responses to interferon-gamma are dependent on cystatin C levels[J]. Int J Biochem Cell Biol, 2009, 41(11): 2262-2269.
[7]
Naruse H, Ishii J, Kawai T, et al. Cystatin C in acute heart failure without advanced renal impairment[J]. Am J Med, 2009, 122(6): 566-573.
[8]
García Acuna JM, González-Babarro E, Grigorian Shamagian L, et al. Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome[J]. Rev Esp Cardiol, 2009, 62(5): 510-519.
[9]
Grubb A, L？fberg H. Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis[J]. Proc Natl Acad Sci USA, 1982, 79(9): 3024-3027.
[10]
Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction[J]. Circulation, 2007, 116(22): 2634-2653.
[11]
Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol, 1983, 51(3): 606-606.
[12]
Shi GP, Sukhova GK, Grubb A, et al. Cystatin c deficiency in human atherosclerosis and aortic aneurysms[J]. J Clin Invest, 1999, 104(9): 1191-1197.
[13]
Cheng XW, Kuzuya M. Sasaki T, et al. Increased expression of elastolytic cysteine proteasesa,cathepsins S and K, in the neointima of balloon-injured rat carotid arteries[J]. Am J Pathol, 2004, 164(1): 243-251.
[14]
Luc G, Bard JM, Lesueur C, et al. Plasma cystatin-C and development of coronary heart disease: the PRIME Study[J]. Atherosclersis, 2006, 85(2): 375-380.
[15]
Koeni W, Twardella D, Brenner H, et al. Plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rat[J]. Clin Chem, 2005, 51 (2): 321-327.
[16]
Kilic T, Oner G, Ural E, et al. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome[J]. Atherosclerosis, 2009, 207(2): 552-558.
